MEDISCRIPT LIMITED

Company number 02128686 ·

Dissolved

4 notices naming this company in The Gazette, the UK's official public record

24 January 2022

MEDISCRIPT LIMITED (Company Number 02128686) Registered office: Mountview Court, 1148 High Road, Whetstone, London N20 0RA Principal trading address: 1 Mountview Court, 310 Friern Barnet Lane, London N20 0LD Notice is hereby given that I, Andreas Arakapiotis (IP No. 20910) of Kallis & Company, Mountview Court, 1148 High Road, Whetstone, London, N20 0RA the Liquidator of the above-named Company, intend declaring a final dividend to the non-preferential unsecured creditors within two months of the last date for proving specified below. Creditors who have not already proved are required, on or before 15 February 2022, the last date for proving, to submit a proof of debt to me at Kallis & Company, Mountview Court, 1148 High Road, Whetstone, London, N20 0RA and, if so requested by me, to provide such further details or produce such documentary or other evidence as may appear to be necessary. A creditor who has not proved his debt before the date specified above will be excluded from the distribution. Date of Appointment: 10 March 2020 For further details contact Christina Chrysanthou, Tel: 020 8446 6699; Email: [email protected] Andreas Arakapiotis, Liquidator 18 January 2022 Ag MH101152

Source document (PDF)

23 March 2020

Name of Company: MEDISCRIPT LIMITED Company Number: 02128686 Nature of Business: Secreterial / conference and event management / medical publishing Type of Liquidation: Members Registered office: 1 Mountview Court, 310 Friern Barnet Lane, London N20 0LD Liquidator(s): Andreas Arakapiotis of Kallis & Company, Mountview Court, 1148 High Road, Whetstone, London Office Holder Number: 020910 . Date of Appointment: 10 March 2020 By whom Appointed: Members PURSUANT TO SECTION 109 OF THE INSOLVENCY ACT 1986

Source document (PDF)

23 March 2020

MEDISCRIPT LIMITED (Company Number 02128686) ("the Company") — In Members' Voluntary Liquidation Registered office: Mountview Court, 1148 High Road, Whetstone, London, N20 0RA Principal trading address: 1 Mountview Court, 310 Friern Barnet Lane, London N20 0LD NOTICE IS HEREBY GIVEN that the creditors of the above named Company, which was voluntarily wound up on 10 March 2020, are required, on or before 23 April 2020 to send their full names and addresses together with full particulars of their debts or claims to Kallis & Company, Mountview Court, 1148 High Road, Whetstone, London, N20 0RA, and, if so requested by me, to provide such further details or produce such documentary or other evidence as may appear to be necessary, or in default thereof they will be excluded from the benefit of any distribution made before such debts are proved. Note: This is a solvent liquidation and all known creditors have been or will be paid in full. Liquidator: Andreas Arakapiotis (IP No. 020910) of Kallis & Company, Mountview Court, 1148 High Road, Whetstone, London N20 0RA. Date of appointment: 10 March 2020 For further details contact Michalis Thomas on telephone 020 8446 6699, or by email at [email protected]. Andreas Arakapiotis LIQUIDATOR DATED THIS 13TH DAY OF MARCH 2020

Source document (PDF)

23 March 2020

MEDISCRIPT LIMITED ("the Company") — In Members' Voluntary Liquidation (Company Number 02128686) Registered office: 1 Mountview Court, 310 Friern Barnet Lane, London, N20 0LD Principal trading address: 1 Mountview Court, 310 Friern Barnet Lane, London, N20 0LD On the 10 March 2020, the following written resolutions were passed by the shareholders of the Company, as a special resolution and an ordinary resolution respectively: MONEY "That the Company be wound up voluntarily and that Andreas Arakapiotis (IP No 020910) of Kallis & Company, Mountview Court, 1148 High Road, Whetstone, London, N20 0RA be appointed Liquidator of the Company, and that they be authorised to act." For further details contact Michalis Thomas on telephone 020 8446 6699, or by email at [email protected]. Mr Faarid Hashim Patel Director 13 March 2020

Source document (PDF)